Kato, Tadashi Furukawa, Toshi Mantani, Akio Kurata, Ken’ichi Kubouchi, Hajime Hirota, Susumu Sato, Hirotoshi Sugishita, Kazuyuki Chino, Bun Itoh, Kahori Ikeda, Yoshio Shinagawa, Yoshihiro Kondo, Masaki Okamoto, Yasumasa Fujita, Hirokazu Suga, Motomu Yasumoto, Shingo Tsujino, Naohisa Inoue, Takeshi Fujise, Noboru Akechi, Tatsuo Yamada, Mitsuhiko Shimodera, Shinji Watanabe, Norio Inagaki, Masatoshi Miki, Kazuhira Ogawa, Yusuke Takeshima, Nozomi Hayasaka, Yu Tajika, Aran Shinohara, Kiyomi Yonemoto, Naohiro Tanaka, Shiro Zhou, Qi Guyatt, Gordon Additional file 3: of Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial SUN☺D Investigators and committee members. (DOCX 17 kb) Major depressive disorder;Antidepressive agents: first-line treatment;Second-line treatment;Randomised controlled trial 2018-07-11
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_Optimising_first-_and_second-line_treatment_strategies_for_untreated_major_depressive_disorder_the_SUN_D_study_a_pragmatic_multi-centre_assessor-blinded_randomised_controlled_trial/6802763
10.6084/m9.figshare.6802763.v1